Singapore markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
166.41+1.75 (+1.06%)
At close: 04:00PM EDT
166.20 -0.21 (-0.13%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 291.55B
Enterprise value 338.12B
Trailing P/E 60.54
Forward P/E 14.79
PEG ratio (5-yr expected) 0.46
Price/sales (ttm)5.37
Price/book (mrq)28.14
Enterprise value/revenue 6.22
Enterprise value/EBITDA 19.69

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 31.39%
S&P500 52-week change 321.23%
52-week high 3182.89
52-week low 3130.96
50-day moving average 3175.41
200-day moving average 3155.90

Share statistics

Avg vol (3-month) 35.64M
Avg vol (10-day) 35.09M
Shares outstanding 51.77B
Implied shares outstanding 61.77B
Float 81.76B
% held by insiders 10.11%
% held by institutions 171.94%
Shares short (28 Mar 2024) 413.12M
Short ratio (28 Mar 2024) 42.04
Short % of float (28 Mar 2024) 40.74%
Short % of shares outstanding (28 Mar 2024) 40.74%
Shares short (prior month 29 Feb 2024) 414.27M

Dividends & splits

Forward annual dividend rate 46.2
Forward annual dividend yield 43.77%
Trailing annual dividend rate 35.99
Trailing annual dividend yield 33.64%
5-year average dividend yield 44.42
Payout ratio 4217.65%
Dividend date 315 May 2024
Ex-dividend date 412 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 8.95%
Operating margin (ttm)31.81%

Management effectiveness

Return on assets (ttm)8.07%
Return on equity (ttm)35.20%

Income statement

Revenue (ttm)54.32B
Revenue per share (ttm)30.72
Quarterly revenue growth (yoy)-5.40%
Gross profit (ttm)N/A
Net income avi to common (ttm)4.82B
Diluted EPS (ttm)2.72
Quarterly earnings growth (yoy)-66.80%

Balance sheet

Total cash (mrq)12.82B
Total cash per share (mrq)7.26
Total debt (mrq)60.58B
Total debt/equity (mrq)582.66%
Current ratio (mrq)0.87
Book value per share (mrq)5.87

Cash flow statement

Operating cash flow (ttm)22.84B
Levered free cash flow (ttm)22.63B